Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of
Senior Director, Finance – CIO Group, Operations & Technology About CIO, Operations & Technology Do you want to shape how a global technology organisation invests, scales, and delivers impact? Join Thomson Reuters as a strategic finance
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement.read on In 2015, we pioneered a “moneyball for biotech”
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
This position can be based remotely in territory (Switzerland, Germany, or Austria), or remotely near the Swiss border in France. About Us GitGuardian is a global cybersecurity scale-up. The company is based in Paris, New-York City,
Director, Patents & Loss of Exclusivity International Operations Legal, Ethics & Compliance Zurich, Switzerland or Copenhagen, Denmark Step into a highly visible role where your patent expertise helps shape commercial strategy, protect breakthrough medicines, and expand
Work Your Magic with us! Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich
VP, Head of Global Access, Value and Pricing Location: Basel, BS, CH About Idorsia Pharmaceuticals Ltd Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all disciplines
United States Digital Space LLC seeks a Senior Cloud IAM Architect to lead design and delivery of scalable identity and access management solutions in a cloud environment. You will drive architecture, define standards, and mentor engineering teams
Key Responsibilities: Drive the build out of the capabilities on the Ecosystem Platform roadmap. Able to work closely with the applications teams and other architects to drive high quality application development, raising the bar of engineering
Thomson Reuters is enhancing its Cyber Defense capability in response to an AI-driven threat landscape that has fundamentally changed the speed, scale, and nature of cyberattacks. The Distinguished Engineer, AI Threat Defense is an individual contributor
Head of Partnership Development - Americas New York, United States Head of Partnership Development - Americas New York, United States 1 week ago Use AI to assess how you fit Get AI-powered advice on this job
Your responsibilities : Fair marketing & brand experience Serve as the global owner of fair marketing and experiential initiatives, shaping frameworks, prioritisation, final sign-off for integrated campaigns across all Art Basel shows with clear cultural brand
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Nexthink is the leader in digital employee experience (DEX) management software. The company provides IT leaders with unprecedented insight allowing them to see, diagnose and fix issues at scale impacting employees anywhere, with any application or